prikaz prve stranice dokumenta New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine
  Preuzmi
PDF 381.92 KB
Znanstveni rad - Prikaz slučaja
New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine
Cureus, 14 (2022), 7; e27213. https://doi.org/10.7759/cureus.27213
Abičić, Ana; Sitaš, Barbara; Adamec, Ivan; Bilić, Ervina; Habek, Mario

Citirajte ovaj rad

Abičić, A., Sitaš, B., Adamec, I., Bilić, E. i Habek, M. (2022). New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine. Cureus, 14. (7). doi: 10.7759/cureus.27213

Abičić, Ana, et al. "New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine." Cureus, vol. 14, br. 7, 2022. https://doi.org/10.7759/cureus.27213

Abičić, Ana, Barbara Sitaš, Ivan Adamec, Ervina Bilić i Mario Habek. "New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine." Cureus 14, br. 7 (2022). https://doi.org/10.7759/cureus.27213

Abičić, A., et al. (2022) 'New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine', Cureus, 14(7). doi: 10.7759/cureus.27213

Abičić A, Sitaš B, Adamec I, Bilić E, Habek M. New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine. Cureus [Internet]. 24.07.2022. [pristupljeno 08.11.2024.];14(7). doi: 10.7759/cureus.27213

A. Abičić, B. Sitaš, I. Adamec, E. Bilić i M. Habek, "New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine", Cureus, vol. 14, br. 7, Srpanj 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:884277. [Citirano: 08.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:884277
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine
AutorAna Abičić
AutorBarbara Sitaš
AutorIvan Adamec
AutorErvina Bilić
AutorMario Habek
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA NEUROLOGIJU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Neurologija
Sažetak (engleski)
Coronavirus disease 2019 (COVID-19) vaccines have been reported as possible triggers of the production of antibodies pathogenic to the peripheral nerve and neuromuscular junction. We report on a patient who experienced vertical diplopia three weeks after the booster dose of the Pfizer-BioNTech vaccine (Comirnaty®). The diagnosis of myasthenia gravis (MG) was established based on highly positive antibodies to the nicotinic acetylcholine receptor (nAChR). Treatment with pyridostigmine and prednisone was started with gradually raising doses. On a follow-up exam two months after treatment initiation, clinical improvement was noted with an almost normal bulbomotor examination. The occurrence of diplopia following COVID-19 vaccination should raise suspicion of new-onset ocular MG and testing for anti-nAChR antibodies is advised.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Prikaz slučaja
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaCureus
Brojčani podacivol. 14, br. 7, e27213
p-ISSN2168-8184
DOIhttps://doi.org/10.7759/cureus.27213
URN:NBNurn:nbn:hr:105:884277
Datum objave publikacije2022-07-24
URL dokumentahttps://www.cureus.com/articles/105239-new-onset-ocular-myasthenia-gravis-after-booster-dose-of-covid-19-vaccine
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2023-03-21 08:37:39